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Characteristics and regulation of P1 transport in osteogenic cells for
bone metabolism. Inorganic phosphate (Pi) is an essential element in the
development of osteogenic cells. The translocation of Pi from the systemic
to the skeletal extracellular compartment appears to be an important
function of osteoblastic cells. The plasma membrane of osteogenic cells is
endowed with a sodium-dependent Pi transport system that is regulated by
osteotropic factors such as parathyroid hormone (PTH), parathyroid
hormone-related protein (PTHrP), insulin-like growth factor-i (IGF-i),
platelet-derived growth factor (PDGF) and fluoride. A similar Pi transport
system has been recently identified in matrix vesicles derived from the
plasma membrane of osteogenic cells, such as epiphyseal chondrocytes or
osteoblastic cells. Matrix vesicles are extracellular structures which are
considered to play an important role in endochondral and membranous
calcification. Pi transport appears to be the driving force responsible for
the accumulation of mineral inside the matrix vesicles, and thereby can be
considered as a pivotal determinant in the induction of the calcification
process. Furthermore, modulation of the activity of the Pi transport at the
level of the plasma membrane of osteogenic cells by osteotropic factors is
transfered to the matrix vesicles derived from these cells. This notion
implies that hormonal and other environmental factors, such as Pi itself
and calcium, which have a direct impact on the Pi transport activity of
osteogenic cells can also influence the capacity of the matrix vesicles to
initiate the mineralization of the bone matrix. The cellular mechanisms
involved in the regulation of Pi transport by osteotropic factors have been
recently investigated. For the PTH/PTHrP regulatory effect, cAMP ap-
pears to be the main mediator and the response does not require the de
novo synthesis of proteins. For the effects of IGF-i, PDGF and fluoride,
tyrosine phosphorylation processes are involved and responses are depen-
dent upon the de novo synthesis of proteins. The molecules responsible for
activation of these signaling pathways are currently under investigation.
Such an investigation may improve our understanding of the mechanisms
underlying the differentiation processes of osteogenesis such as the
calcification of the extracellular matrix.
The main physiological function of the structure and shape of
bone is to act as a mechanical support. This function is achieved
by the mineralization of an extracellular matrix formed by spe-
cialized cells. Inorganic phosphate (Pi) is an essential element for
the development of osteogenic cells, not only because it is an
integral component of apatite crystal but also because it can affect
the production rate of the bone matrix [1]. Thus, Pi deprivation
interfers with normal osteoblastic function, which in turn influ-
ences the process of mineralization. A positive relation exists
between the plasma P1 level and the rate of skeletal growth and/or
mineralization. Nevertheless, several observations suggest that the
availability of Pi at mineralization sites is not merely dependent
upon its concentration in the systemic extracellular compartment.
The regulated translocation of P1 from the systemic to bone
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extracellular compartment could be an important function of
osteogenic cells. Therefore it is of interest to understand the
handling and regulation of P1 by osteoblastic cells.
Characteristics of Pi transport in bone forming cells
To characterize Pi transport in bone forming cells we used the
ROS 17/2.8 osteoblast-like cell line, which is derived from a rat
osteosarcoma. As in other cell types, Pi uptake in these bone
forming cells was found to be mainly dependent on a Na-coupled
Pi transport system [2]. Analysis of the characteristics of Pi
transport suggested that the Pi carrier(s) of these cells could be
different from those previously described for renal epithelial cells
[3]. Affinity constants were found to be higher for P1 (300 to 500
vs. 50 to 100 fLM) but similar for Na (' 40 mM) as compared to
those described in epithelial cells [3]. It was found that the
translocation of Pi across the plasma membrane from the external
to the intracellular compartment was higher at acidic extracellular
pH. This was probably due to a greater affinity of the transport
system for Pi [2]. This finding contrasted with observations made
in renal and intestinal brush border membrane Pi transport
systems wherein acidic pH was shown to inhibit Pi transport due
to lower affinity of the Pi carrier for Na [4]. In the past decade,
understanding of the mechanism by which P1 enters eucaryotic
cells has made a great deal of progress. The plasma membranes of
epithelial cells and other cell types [5] are equipped with Na-
coupled Pi symport systems which are driven by the inwardly
directed sodium gradient. Using the Xenopus laevis oocyte expres-
sion system, two different epithelial Na/Pi-cotransporters (types I
and II) have been identified [6]. It has been suggested that type I
is a constitutive (unregulated) transporter, whereas type II is a
target for physiological regulations and pathophysiological dys-
regulation. The Na/Pi cotransporter(s) in osteogenic cells has not
yet been identified at the molecular level. However, already
substantial information exists about the characteristics of this
cotransporter both at the cellular level (mentioned above) and in
matrix vesicles derived from either epiphyseal chondrocytes or
osteoblastic cells.
Regulation of P1 transport in osteogenic cells by
calciotropic factors
Parathyroid hormone and parathyroid hormone-related peptide.
In UMR-106 osteoblast-like cells, which are derived from a rat
osteosarcoma, it was first demonstrated that parathyroid hormone
(PTH) stimulates Pi transport via a mechanism that probably
involves cAMP but not de novo protein synthesis [7]. Similar
results were obtained in chicken growth plate chondrocytes in
primary culture [8]. A positive correlation was found between the
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increased Pi transport and the cAMP response to various concen-
trations of PTH [7]. Furthermore, the stimulation of cAMP
production by forskolin reproduced the stimulatory effect of PTH
on Pi transport. The change in Pi transport induced by PTH did
not influence the transporter of alanine which also uses the
Na-gradient driving force for the translocation of this amino-acid
across the plasma membrane. This observation indicated that the
change in Pi transport induced by this calciotropic hormone
resulted from the alteration of a specific mechanism. The change
in Pi transport induced by the PTH-related peptide (PTHrP) was
very close to that of PTH [9], suggesting that both peptides act
through the same receptor. These data provided the first experi-
mental evidence that a major calciotropic hormone such as PTH
could selectively regulate the handling of Pi by osteoblastic cells.
Note that the stimulation of cellular cAMP by PTH in osteoblast-
like cells leads to a functional response opposite to that observed
in kidney epithelial cells [10]. Elucidating the mechanism(s) by
which PTH can selectively either stimulate Pi transport in osteo-
genie cells or inhibit it in kidney cells may provide key information
on transduction system(s) connected to the PTH receptor in
different target tissues.
Extracellular P1
The influence of the extracellular Pi concentration on Pi
transport activity in osteoblast-like cells was very similar to that
described in most eucaryotic cells, In MC3T3-E1 osteoblast-like
cells, which are immortalized osteoblasts derived from mice
calvaria, Pi transport activity was stimulated by lowering the Pi
concentration in the culture medium [11]. The physiological
importance of this in vitro observation remains to be assessed.
Theoretically, if one considers that bone forming cells could be
involved in the transfer of Pi from the systemic compartment to
the bone matrix, this regulatory process could play a significant
role for the calcification of unmineralized bone matrix in patho-
logical conditions associated with phosphate deficiency.
IGF-1 and PDGF
Further studies also showed a stimulatory effect of IGF-1 on Pi
transport in osteoblast-like cells. The cellular mechanisms in-
volved in this response seem to vary according to the osteogenic
cell type used. In primary cultures of epiphyseal growth plate
chondrocytes, the IGF-1 effect was found to be selective for the
Na-dependent Pi transport [8]. The response was directly related
to the duration of exposure to IGF-1 and it was maintained for
several hours. Similar characteristics, including the requirement
for new protein synthesis, were reported in renal epithelial cells
[12]. In MC3T3-E1 cells, IGF-1 also exerted a selective stimula-
tory action on Pi transport. However, the effect was more rapidly
expressed as compared to epiphyseal growth plate chondrocytes in
culture and the response was transient. Furthermore, the change
in Pi transport was not affected when the translational system was
inhibited by cycloheximide (Caverzasio et al, unpublished obser-
vations). The two different kinds of responses observed in the
different cell types were mimicked by vanadate, a strong inhibitor
of tyrosine phosphatases. Indeed, the characteristics of the vana-
date effect on Pi transport were quite similar to those observed
with IGF-1 in terms of time course, selectivity and requirement of
de novo protein synthesis. In addition, vanadate and IGF-1 effects
on Pi transport, when tested at submaximal concentrations, were
not additive, suggesting a common regulatory mechanism [12].
These findings suggest that changes in tyrosine phosphorylation
induced by the type 1 IGF receptor are the initial events in the
signal transduction pathway regulating changes in Pi transport in
response to IGF-1. In favor of this hypothesis, we recently found
that the platelet-derived growth factor (PDGF), a potent bone cell
mitogen, selectively enhanced Pi transport in osteoblast-like cells
in a time- and dose-dependent manner. Experimental evidence
suggests that tyrosine autophosphorylation of the PDGF receptor
and activation of the PLCy-PKC pathway are involved in this
regulatory response (unpublished observations).
Fluoride
The foregoing knowledge prompted us to explore whether
fluoride, another osteogenic agent, could affect Pi transport in
osteoblasts. Indeed, fluoride remains a unique agent that is able to
increase the mass of trabecular bone [13]. In UMR-106 osteo-
blast-like cells, fluoride induced a dose- and a time-related
stimulation of Pi transport [14]. The change in Pi transport with
fluoride was selective and was not associated with alteration in
cellular cAMP level. It was completely blunted by inhibition of
translational processes with cycloheximide. These characteristics
of Pi transport stimulation induced by fluoride were quite similar
to those obtained with IGF-1 in kidney cells [12]. The role of
tyrosyl phosphorylation processes was therefore investigated. In
UMR-106 cells exposed to fluoride, a significant increase in
tyrosine phosphorylation activity was detected in cytosolic and
plasma membrane fractions [15]. The changes in Pi transport in
UMR-106 cells and tyrosine phosphorylation activities in both
cytosolic and plasma membrane fractions were completely inhib-
ited by genistein, an inhibitor of tyrosine kinase. In these cellular
fractions, there was no evidence for alteration in tyrosine phos-
phatase activity, suggesting that fluoride effects on Pi transport are
probably mediated by changes in the activity of a tyrosine kinase
[15]. Recently, we also found that traces of aluminum markedly
enhanced the stimulation of Pi transport induced by fluoride in
osteoblast-like cells, suggesting that a fluoroalumino complex
might be the molecule responsible for activation of an as yet
unknown regulatory pathway [16]. Associated with this enhanced
Pi transport stimulation induced by the combination of fluoride
and aluminum, a marked increase in the phosphorylation of
several proteins on tyrosine residues was observed, further sug-
gesting that a tyrosine phosphorylation process is involved in the
regulation of Pi transport stimulation by fluoride in osteoblast-like
cells.
These observations indicate that protein tyrosine phosphoryla-
tion, besides mediating the effect of osteogenic agents on cell
proliferation, is also involved in regulating Pi transport in bone
forming cells.
The functional role of Pi transport during the different phases
of the development of bone forming cells remains to be investi-
gated. In particular, whether osteoblasts are involved in the
transfer of Pi from the systemic compartment toward the bone
matrix for the maturation of the calcification process is an
interesting issue. Recent experimental evidence suggests that Pi
transport could play a major role in initial events involved in the
process of primary calcification.
Matrix vesicles and Pi transport for bone matrix calcification
With respect to the initiation of calcification of skeletal tissues,
one should recall the fundamental concept presented nearly 40
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years ago by W.F. Newman and M.W. Newman in their classical
treatise on the "Chemical dynamics of bone minerals" [17]. As
stated in the chapter of this book devoted to the mechanism of
calcification, "Normal serum is undersaturated with respect to
secondary calcium (CaHPO4 2HO), but supersaturated with
respect to hydroxyapatite (Ca10(P04)6(OH)2) "In the
formed bone, the cells are faced with the problem of being
literally engulfed by a surfeit of calcium and phosphate. They must
actively resist the pressure of the supersaturated fluids which
tends to increase mineralization" At the same time, in areas
of forming bone and cartilage, the cells after laying down matrix,
are faced with the problem of completing their task-mineralizing
their matrix; they are supplied with fluids containing calcium and
phosphate in concentration now insufficient to induce precipita-
tion of new crystals." In relation with this fundamental concept,
two general and not mutually exclusive theories have been put
forward [18] to account for the initiation of calcification. The first
theory holds that the collagen fibril is the major site of crystal
nucleation such that calcium-phosphate crystals are deposited in
the hole region of these fibrils. While this simple theory is
attractive, more attention has focused on the alternate theory
involving matrix vesicles. Matrix vesicles are produced by osteo-
genic cells. Once calcified in the extracellular matrix, they serve as
nucleation sites for the mineralization of the matrix. Matrix
vesicles are small organelles with a diameter of 100 to 200 nm that
have been observed in mineralizing tissues and cultures of osteo-
genic cells, often in contact with initial mineral crystals. It is
generally accepted, on the basis of histological evidence, that
matrix vesicles arise from bone forming cells via a process of
budding from the elongated tubular extensions that project from
the plasma membrane of these cells [19].
Matrix vesicles have been observed by electron microscopy
mainly in cartilage, bone, dentin, and deer antler, and are also
associated with foci of early calcification in several pathological
conditions such as in arteriosclerosis. They contain large amounts
of alkaline phosphatase and some ATPase and 5' nucleotidase, a
marker enzyme of the plasma membrane.
The mechanism of matrix vesicle-mediated calcification is not
yet fully understood. Several lines of evidence indicate that uptake
of mineral ions by matrix vesicles from the extracellular environ-
ment is required for the initiation of the calcification of these
organelles. It has also been suggested that uptake of mineral ions
is dependent on the prior presence of labile forms of mineral
within the vesicles that serve as a trap for newly entering mineral
ions [20]. The mechanisms by which Ca2 and Pi accumulate in
matrix vesicles have been recently further investigated. Based on
the observation that treatment of matrix vesicles with graded
amounts of proteases causes progressive ablation of their ability to
accumulate Ca2, it has been proposed that Ca2 enters matrix
vesicles via a protease-sensitive carrier [21].
Concerning the mechanism of Pi uptake in matrix vesicles,
alkaline phosphatase has been considered for a long time to play
an important role in this process. However, experimental evidence
indicates that removal of this ectoenzyme from the surface of
matrix vesicles by treatment with phospholipase C did not modify
substantially the capacity of these structures to accumulate min-
eral [22]. This observation did not support the concept that this
enzyme could function as a Pi-transporter for the accumulation of




Fig. 1. Schematic representation of essential matrix vesicles elements in-
volved in calcification and their origin from the plasma membrane of bone
forming cells. Among these elements are Ca2 bound to acidic phospho-
lipids, alkaline phosphatase attached to the external surface of the plasma
membrane and the Na-dependent Pi transport system which likely plays an
important role in initial events responsible for matrix vesicle calcification.
Characterization of a Pi transport system in isolated
matrix vesicles
Most information on matrix vesicle-mediated calcification pro-
cesses have been derived from chicken growth plate chondrocytes.
For this reason, the same experimental system was used to
characterize Pi transport in these organelles. Since ion uptake in
matrix vesicles is likely to be involved in the initial events of matrix
vesicle calcification, it was important to isolate these vesicles in an
non-mineralized form. Experimentally, this was achieved by ex-
tracting these organelles from slices of growth plate cartilage of
chicken fed a rachitic diet [23].
Considering the information that bone forming cells accumu-
late Pi via a Na-coupled Pi transport system and that matrix
vesicles probably derive from the plasma membrane of osteogenic
cells, it was hypothesized that matrix vesicles might have a similar
Pi transport system. Recent findings indicate that an important
part of Pi entry into matrix vesicles is dependent on the presence
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three to five times greater in the presence of 150 mrvi NaC1
compared with the same concentration of choline chloride. This
observation was the first evidence that matrix vesicles are en-
dowed with an active Na-Pi cotransport system. This system
exhibits properties similar to those described for the Pi transport
system present in the plasma membrane of bone forming cells
(Fig. 1). Of interest, the Na-dependent Pi transport in matrix
vesicles was not related with alkaline phosphatase activity. Lev-
amisole which markedly inhibited this enzyme activity did not
influence Na-dependent Pi transport [23]. These observations
were quite consistent with the notion that alkaline phosphatase is
not involved in Pi transport of matrix vesicles.
Na-dependent Pi transport and calcification of matrix vesicles
As mentioned above, the uptake of mineral ions by matrix
vesicles is required for initiating the calcification process. The role
of Na-Pi cotransport activity for the development of this process
was therefore investigated. Radioisotopic accumulation of Ca2
and Pi by these organelles was determined in a synthetic lymph
medium containing either sodium or choline chloride. As shown
in Figure 2 [23], the presence of sodium in the extravesicular
medium was required for the accumulation of Pi and Ca2 by
matrix vesicles. Furthermore, Pi accumulation in matrix vesicles
preceded by several hours the accumulation of Ca2t This obser-
vation suggested the following sequence of events: First, Pi
accumulates inside of matrix vesicles and probably binds to
Ca2 tphospholipid complexes to form the first nucleation sites.
Then, the process of calcification proceeds by a booster mecha-
nism leading to complete mineralization of the matrix vesicles. In
this system, the driving force sustaining the intravesicular accu-
mulation of Pi transport cannot be the Na-gradient across the
plasma membrane since this gradient is not maintained once the
vesicles leave the cells. Instead, since Pi inside the vesicles rapidly
binds to Ca2-phospholipid complexes and it is likely that this
reaction is maintained by a favorable Pi gradient, allowing the
continuation of the Pi transfer inside the matrix vesicles. In this
system, Na only facilitates the translocation of Pi across the
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Fig. 3. Expression of Na-dependent Pi transport activity in matrix vesicles
isolated from cultured MC3T3-E1 osteoblast-like cells. A low Pi transport
activity is recorded during the proliferative phase. At the time of cell
differentiation, when osteoblast-like cells lay down an extracellular matrix,
Pi transport activity is markedly increased with a gradual return to
baseline activity with time in culture.
Expression of Na-coupled Pi transport in matrix vesicles
during the differentiation of bone forming cells
The notion that the Na-coupled Pi transport system is involved
in initial events of matrix vesicle-calcification and the origin of
these structures from the plasma membrane of bone forming cells
suggested the existence of specific process(es) through which
these cells might control initial events leading to the mineraliza-
tion of their extracellular matrix. Indeed, compelling evidence
indicate that epiphyseal chondrocytes, osteoblasts or odontoblasts
do not simply secrete extracellular organic molecules for the
formation of a calcified matrix but actively participate in the
















Fig. 2. Accumulation of (A) ino,anic
phosphate (Pi) and (B) calcium (Ca2) in
matrix vesicles isolated from chicken growth plate
cartilage. In the presence of sodium chloride(•) in the synthetic cartilage lymph medium, Pi
first gradually accumulates during several hours
25 before rapid uptake of both Ca2 and Pi. These









Fig. 4. Schematic representation of regulatory
factors and their signal transduction mechanisms
known to stimulate Na-coupled Pi transport in
osteoblast-like cells. As mentioned in the text,
experimental evidence has been obtained
suggesting parallel regulation of Pi transport
activity in the plasma membrane of bone
forming cells and in their derived matrix
vesicles. With the notion that the Pi transport
activity in matrix vesicles is important for
accumulation of mineral ions, it is hypothesized
that the regulation of Pi transport activity in
matrix vesicles by osteogenic cells might play a
significant role in the control of processes
involved in the calcification of bone matrix.
involved in the development of this complex function, we inves-
tigated the expression of the Pi transport activity in matrix vesicles
during the differentiation of bone forming cells. These studies
were carried out in MC3T3-E1 osteoblast-like cells derived from
mouse calvaria. These cells in culture have been shown to produce
matrix vesicles and a collagenous extracellular matrix which
calcifies in vitro. Furthermore, the different phases of proliferation
and differentiation of MC3T3-E1 cells have been well character-
ized [24]. We recently found (Fig. 3, [11]) that Pi transport activity
was low in matrix vesicles released during the proliferative phase.
During the phase of differentiation which corresponds to the
synthesis of a collagenous matrix, Pi transport activity in released
matrix vesicles was significantly expressed. After completion of
bone matrix formation, Pi transport activity gradually returned to
initial baseline values. This observation strongly suggests the
existence of a specific mechanism for enhanced Pi transport
activity in matrix vesicles released during the formation of the
collagenous matrix. It could be explained by either enrichment of
Pi carriers in released matrix vesicles or formation of specific
matrix vesicles having high Pi transport activity at that time period
of the differentiation process.
Regulation of Pi transport activity in matrix vesictes and its
physiological significance
Besides the above-described mechanism of enhanced Pi trans-
port activity in matrix vesicles released during the formation of the
bone matrix, it was considered that changes in Pi transport activity
in the plasma membrane of osteogenic cells induced by calciotro-
pic factors might be transfered to matrix vesicles. In the
MC3T3-E1 experimental system, exposure of osteoblast-like cells
to growth factors enhanced Pi transport in both the plasma
membrane and the released matrix vesicles [11]. Similar results
were obtained by modifying the extracellular concentration of Pi.
Culture of MC3T3-E1 cells in medium containing a low Pi
concentration induced a stimulation of Pi transport activity [11].
As observed with growth factors, this change in Pi transport
activity was also transfered to released matrix vesicles [111. These
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observations indicate that in addition to the existence of a
selective process for the insertion of active Pi carriers into the
membrane of matrix vesicles, the number or activity of the
inserted Pi transport systems also influences Pi transport activity
in released matrix vesicles. The physiological importance of this
transfer of Pi transport activity from the osteogenic cell to the
matrix vesicles in response to stimulatory factors remains to be
explored. It is, however, conceivable that during rapid bone
growth, rate-limiting mechanisms responsible for initiation and
development of matrix calcification would operate more effi-
ciently. In this context, a higher Pi transport activity in matrix
vesicles would accelerate initial events for Ca2 and Pi accumu-
lation and allow the bone matrix mineralization to proceed more
rapidly.
Conclusions
The recent findings reported in this paper suggest that, among
the various processes reponsible for the differentiation of bone
forming cells, the development of the bone matrix calcification is
likely to be influenced by Pi. The activity of the Pi transport
system in osteogenic cells can be regulated by several calciotropic
factors and the change in Pi transport activity induced by growth
factors is also observed in matrix vesicles. If alteration in Pi
transport activity modulates the process of calcification of these
structures, a relationship which remains to be demonstrated, one
could speculate that the regulation of Pi transport activity in
osteogenic cells might represent a mechanism by which osteogenic
cells regulate the calcification of their extracellular matrix. If this
relationship can be demonstrated, it is likely that potential
hormonal or local factors are involved in this regulatory process
by acting on specific cellular mechanisms (Fig. 4). Important
progress in this field of research is expected as soon the bone Pi
transport system will be identified and specific molecular tools will
become available. Finally, whether other important functions of
bone forming cells such as responses to mitogenic factors or the
formation of the bone matrix are also influenced by inorganic
phosphate are interesting aspects which remain to be investigated.
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